Geneva (ots) - The Unilabs laboratory in Lugano (Tessin) has signed an agreement with two hospital establishments located in the Lugano area. These hospitals comprise a total of 150 beds and accommodate around 6,500 hospitalized patients and 32,000 outpatients per year. The contract, which takes effect immediately, relates to an estimated annual turnover of CHF 1.5 million and a minimum period of until December 31, ...
Geneva (ots) - Biocheckup tests will allow early detection of signs of illness and permit evaluation of the risk factors for diseases such as diabetes, cancer or cardiovascular disease Most people are concerned by the state of their health and would like to know their predisposition to different pathologies before they become established (e.g. diabetes, cancer, ...
Geneva (ots) - Novo Nordisk Switzerland announced today that Levemir® (insulin detemir), a novel, predictable basal insulin analogue with a unique mechanism of prolonging action (scientifically known as protraction), is available for people with type 1 and type 2 diabetes in Switzerland today. The Swiss launch is just the beginning of an exciting global roll-out of ...
Volketswil (ots) - JUVENA of Switzerland is the first cosmetics company world-wide to integrate technology from the field of emergency medicine into skin care products. The basis for this technology is the research work of Professor Odile Damour*, head of the Laboratoire des Substituts Cutanés in Lyon (FR) and authority in the field of biological skin ...
Volketswil (ots) - JUVENA of Switzerland is working side by side with a strong partner: Professor Odile Damour, an authority in the field of natural skin reconstruction. She heads the Laboratoire des Substituts Cutanés of the University of Lyon, one of the leading institutes for the healing of burn related injuries. JUVENA of Switzerland decided at the beginning of ...
London, UK plc (LSE:ASM, NASD-E:ASOM) (ots) - Antisoma announces that results from its phase I biodistribution study of AS1403 (formerly TheraFab) will be presented this weekend to the European Association of Nuclear Medicine meeting in Amsterdam by Dr Michael Garkavij, a leading investigator in the trial. AS1403 is a fragment of the monoclonal antibody HMFG1 linked to a radioactive isotope with cell-killing ...
Brussels, Belgium (ots) - Universite Louis Pasteur Strasbourg Invited to Demonstrate Health Hero Network Technology at 'The Contribution of ICT to Health' Ministerial Conference and Exhibition 22-23 May -- Brussels Health Hero Network, Ltd. was selected with Universite Louis Pasteur (ULP) Strasbourg to present its Health Buddy(R) in-home health monitoring ...
International Herpes Management Forum (I
Paris (ots) - Patient and Physician Insights Presented at International Herpes Management Forum Annual Meeting Many people living with genital herpes are not satisfied with how this common infection is managed, according to the results of a year-long international survey of patients and physicians presented at this weekend's 10th Annual Meeting of the ...
AMHERST, NH/USA (ots) - With Enterprise-Class Features, Ektron CMS200 and CMS300 Continue to Offer "Lowest Total Cost Of Ownership" Among Mid-Tier CMS Solutions Ektron today unveiled features that enhance flexibility and scalability of Ektron CMS200 and Ektron CMS300, including new support for Microsoft® ...
The Business Humanitarian Forum
Geneva (ots) - Under the aegis of The Business Humanitarian Forum, representatives from businesses, United Nations system agencies, and foundations gathered this afternoon for a workshop entitled "Combating the HIV/AIDS Epidemic in Africa: Mother to Child Transmission Prevention". The participants discussed ...
IREF-Ischemia Research and Education Fou
SAN FRANCISCO, CA (ots) - Landmark study published in the New England Journal of Medicine identifies safe, inexpensive therapy to save lives and healthcare costs Led by Dr. Dennis T. Mangano and the Ischemia Research & Education Foundation, a massive, worldwide study involving 17 countries, 70 medical ...
Nat. Council of State Boards Nursing
CHICAGO, IL (ots) - The National Council of State Boards of Nursing (NCSBN) (www.ncsbn.org) recently approved a recommendation from its Examination Committee to proceed with negotiations for a contract amendment with its test service vendor (Pearson, plc.) for purposes of international administration of the NCLEX(R) examinations. At its 2002 Delegate Assembly (held ...
Karolinska Institute, Stockholm
Stockholm, Sweden (ots) - Subcutaneous administration of the first and only monoclonal antibody, MabCampath(R)/Campath(R) (alemtuzumab), approved for treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (B-CLL) patients (33 percent response), elicited an overall response of 87 percent in ...
Basel (ots) - * First-quarter Group sales up 13% in local currencies (10% in Swiss francs) * Pharmaceuticals extends double-digit sales growth (+16% in local currencies; +14% in Swiss francs), driven by strong demand for cardiovascular, oncology and ophthalmic products in all regions * Net profits surge ...
Q3/2001 once more with definite sales and earnings gains Safety Technology strong Medical Technology reaping restructuring benefits Luebeck, Germany (ots) - With 9-month sales and earnings buoyant, Luebeck-based Draegerwerk AG is progressing well along the turnaround road leading to its back-to-the-black destination for 2001. As announced by this Medical & Safety Technology Group, consolidated three-quarter sales advanced by 13.6 percent to Euros 825.6 million (up ...
Giessen, Germany (ots) - Diabetes mellitus and cancer are among the diseases of greatest clinical focus. At the ScheBo Biotech AG Symposium during MEDICA on the occasion of the World Congress of Pathology and Laboratory Medicine (WASPaLM) 2001 two specific diagnostic tools with unique clinical approaches will be ...